Brain iron levels in attention-deficit/hyperactivity disorder normalize as a function of psychostimulant treatment duration

Autor: Joseph A. Helpern, Jens H. Jensen, Vitria Adisetiyo, Kevin M. Gray
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
GP
globus pallidus

Red nucleus
Treatment duration
R2
Caudate nucleus
lcsh:RC346-429
0302 clinical medicine
PUT
putamen

Basal ganglia
Brain iron
Medicine
Child
Putamen
05 social sciences
Brain
Regular Article
Magnetic Resonance Imaging
MFC
magnetic field correlation

Globus pallidus
Neurology
lcsh:R858-859.7
MRI
CN
caudate nucleus

medicine.medical_specialty
Adolescent
Cognitive Neuroscience
Iron
Thalamus
Magnetic field correlation
lcsh:Computer applications to medicine. Medical informatics
050105 experimental psychology
03 medical and health sciences
Internal medicine
Attention deficit hyperactivity disorder
ADHD
Humans
0501 psychology and cognitive sciences
Radiology
Nuclear Medicine and imaging

RN
red nucleus

lcsh:Neurology. Diseases of the nervous system
Duration of Therapy
business.industry
medicine.disease
Endocrinology
Attention Deficit Disorder with Hyperactivity
THL
thalamus

Central Nervous System Stimulants
Neurology (clinical)
business
030217 neurology & neurosurgery
Psychostimulants
Zdroj: NeuroImage : Clinical
NeuroImage: Clinical, Vol 24, Iss, Pp-(2019)
ISSN: 2213-1582
Popis: Brain iron homeostasis is a dopamine-related mechanism that may be modified with long-term psychostimulant treatment in attention-deficit/hyperactivity disorder (ADHD). We previously reported that while medication-naïve youth with ADHD have reduced brain iron compared to controls and psychostimulant-medicated patients, no differences were detected between the latter groups. In this follow-up study, we examined whether the duration of psychostimulant treatment correlates with the degree of iron normalization. Brain iron was indexed with MRI using an advanced method called magnetic field correlation (MFC) imaging and the conventional R2* proton transverse relaxation rate method. MFC was acquired in 30 psychostimulant-medicated youth with comorbid-free ADHD and 29 age-matched controls (all males). R2* was acquired in a subset of these individuals. Region-of-interest analyses for MFC and R2* group differences and within-group correlations with age and years of psychostimulant treatment were conducted in the globus pallidus (GP), putamen (PUT), caudate nucleus (CN), thalamus (THL) and red nucleus. No significant MFC and R2* group differences were detected. However, while all regional MFC and R2* significantly increased with age in the control group, MFC and R2* increased in the GP, PUT, CN and THL with psychostimulant treatment duration in the ADHD group to a greater degree than with age. Our findings suggest that while youth with ADHD may have less prominent age-related brain iron increases than that seen in typical development, long-term use of psychostimulant medications may compensate through a normalizing effect on basal ganglia iron. Longitudinal studies following ADHD patients before and after long-term psychostimulant treatment are needed to confirm these findings.
Highlights • Brain iron does not differ between controls and psychostimulant-medicated ADHD. • Brain iron increases with age in controls. • Brain iron increases with psychostimulant use duration in ADHD more than with age. • Long-term psychostimulant treatment of ADHD normalizes brain iron levels.
Databáze: OpenAIRE